What top creators are saying about Alnylam Pharmaceuticals, Inc.(ALNY)
A biotechnology company credited as a pioneer in RNA medicines (siRNA).
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Alnylam Pharmaceuticals, Inc. in the last 30 days yet.
Top creators covering Alnylam Pharmaceuticals, Inc. (ALNY)
The 1 sources with the most insights about Alnylam Pharmaceuticals, Inc. on Kazuha.
Latest insights about Alnylam Pharmaceuticals, Inc. (ALNY)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, February 16, 2026
Credited for its decades of foundational work that led to the success of RNA therapeutics, now considered a 'de-risked modality' and a 'mature platform'.
Monday, February 16, 2026
Credited for its decades of foundational work that led to the success of RNA therapeutics, now considered a 'de-risked modality' and a 'mature platform'.
Discussed alongside Alnylam Pharmaceuticals, Inc. (ALNY)
Other assets that creators frequently mention in the same content as Alnylam Pharmaceuticals, Inc..
Frequently asked
Which podcasters and creators cover Alnylam Pharmaceuticals, Inc. (ALNY) the most?
The most active sources covering Alnylam Pharmaceuticals, Inc. (ALNY) on Kazuha are Andreessen Horowitz. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Alnylam Pharmaceuticals, Inc. (ALNY) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Alnylam Pharmaceuticals, Inc. (ALNY) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Alnylam Pharmaceuticals, Inc. (ALNY)?
Creators covering Alnylam Pharmaceuticals, Inc. (ALNY) most frequently also discuss PLTR, GSK, NVS, SDZ, PFE. See the "Discussed alongside" section above for full asset pages.